DOCSLIB.ORG

Epidemiology of Abnormal Uterine Bleeding 25 Michael Zinger 5

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Epidemiology of Abnormal Uterine Bleeding 25 Michael Zinger 5 Modern Management…Uterine Bleeding rev2:Modern Management…Uterine Bleeding rev2 9/1/08 10:24 Page 1 Modern Management of O’Donovan O’Donovan ABNORMAL • UTERINE BLEEDING Miller Modern Management of Modern Management of Abnormal Uterine Bleeding is written by an internationally recognized team of experts – many of whom are at the forefront of developing 'second-generation' endometrial ablation techniques as well as ABNORMAL UTERINE BLEEDING Modern Management of standard practice. The book covers the full range of surgical and medical treatments, including the background, diagnosis and treatment. ABNORMAL This must have book will help gynecologists refine their operative techniques and consider new approaches to this highly challenging condition. UTERINE BLEEDING Edited by Peter Joseph O`Donovan FRCOG FRCS (ENG) Consultant Gynaecologist and Gynaecological Cancer Lead Director MERIT Centre, Bradford Teaching Hospitals NHS Trust, Bradford and Professor of Medical Innovation, Bradford University, Bradford,UK Charles E Miller MD FACOG Director of Minimally Invasive Gynecologic Surgery, Lutheran General Hospital, Park Ridge, and Clinical Associate Professor, Department of Obstetrics and Gynecology, University of Chicago, and Clinical Associate Professor, Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, IL, USA Cover illustration: ‘The Uterine’ by Elizabeth Gray © UK 2008 Edited by ISBN 978-0-415-45479-7 Peter Joseph O’Donovan www.informahealthcare.com 9 78041 5 454797 Charles Miller MODERN MANAGEMENT OF ABNORMAL UTERINE BLEEDING Edited by Peter Joseph O’Donovan FRCOG FRCS(ENG) Consultant Gynaecologist and Gynaecological Cancer Lead, Director, MERIT Centre, Bradford Teaching Hospitals NHS Trust, Bradford, and Professor of Medical Innovation, Bradford University, Bradford, UK Charles E Miller MD FACOG Director of Minimally Invasive Gynecologic Surgery, Lutheran General Hospital, Park Ridge, and Clinical Associate Professor, Department of Obstetrics and Gynecology, University of Chicago, and Clinical Associate Professor, Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, IL, USA © 2008 Informa UK Ltd First published in the United Kingdom in 2008 by Informa Healthcare, Telephone House, 69-77 Paul Street, London EC2A 4LQ. Informa Healthcare is a trading division of Informa UK Ltd. Registered Office: 37/41 Mortimer Street, London W1T 3JH. Registered in England and Wales number 1072954. Tel: +44 (0)20 7017 5000 Fax: +44 (0)20 7017 6699 Website: www.informahealthcare.com All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior permission of the publisher or in accordance with the provisions of the Copyright, Designs and Patents Act 1988 or under the terms of any licence permitting limited copying issued by the Copyright Licensing Agency, 90 Tottenham Court Road, London W1P 0LP. Although every effort has been made to ensure that all owners of copyright material have been acknowledged in this publication, we would be glad to acknowledge in subsequent reprints or editions any omissions brought to our attention. Although every effort has been made to ensure that drug doses and other information are presented accurately in this publica- tion, the ultimate responsibility rests with the prescribing physician. Neither the publishers nor the authors can be held respon- sible for errors or for any consequences arising from the use of information contained herein. For detailed prescribing information or instructions on the use of any product or procedure discussed herein, please consult the prescribing information or instructional material issued by the manufacturer. A CIP record for this book is available from the British Library. Library of Congress Cataloging-in-Publication Data Data available on application ISBN-10: 0 415 45479 4 ISBN-13: 978 0 415 45479 7 Distributed in North and South America by Taylor & Francis 6000 Broken Sound Parkway, NW, (Suite 300) Boca Raton, FL 33487, USA Within Continental USA Tel: 1 (800) 272 7737; Fax: 1 (800) 374 3401 Outside Continental USA Tel: (561) 994 0555; Fax: (561) 361 6018 Email: [email protected] Distributed in the rest of the world by Cengage Learning Services Limited Cheriton House North Way Andover, Hampshire SP10 5BE, UK Tel: +44 (0)1264 332424 Email: [email protected] Composition by Exeter Premedia Services Private Ltd., Chennai, India Printed and bound in India by Replika Press Pvt. Ltd I would like to dedicate this book to my parents, Patrick and Sheila and also my loving wife Carmel and children, James, Olivia, Charles and Niamh, who have always been a constant source of encouragement to me. Peter Joseph O’Donovan I would like to dedicate this book to the women in my life – my mother, Muriel, my daughter, Abagayle and my loving wife Laura. Charles E Miller Contents List of contributors ix Preface xiii Acknowledgments xiv SECTION I BACKGROUND 1. Menstruation: historical perspective 1 James Drife 2. Physiology of menstruation 11 Michael Zinger 3. Terminologies and definitions around abnormal uterine bleeding 17 Ian S Fraser, Hilary OD Critchley, and Malcolm G Munro 4. Epidemiology of abnormal uterine bleeding 25 Michael Zinger 5. Practical assessment and measurement of abnormal uterine bleeding 29 Ian S Fraser, Pamela Warner, and Hilary OD Critchley 6. Pathogenesis of abnormal uterine bleeding 34 Malcolm G Munro and Ian S Fraser 7. Menstrual problems in adolescence 41 D Keith Edmonds 8. Menstrual dysfunction secondary to medical diseases 48 Tharani Balasubramaniam and LA Parapia SECTION II DIAGNOSIS 9. The role of ultrasound in investigating abnormal uterine bleeding 58 Maha Alkatib and Thomas H Bourne 10. The role of hysteroscopy in investigating abnormal uterine bleeding 64 Aarathi Cholkeri-Singh and Keith B Isaacson SECTION III TREATMENT 11. Medical management of abnormal uterine bleeding 71 Margaret CP Rees v vi Contents 12. The levonorgestrel intrauterine system 79 Diana Mansour 13. Current surgical treatment options: an evidence-based approach 89 Erik Qvigstad and Olav Istre 14. The use of contemporary energy modalities during operative laparoscopy 94 Andrew I Brill 15. Hysteroscopic rollerball endometrial ablation 100 George A Vilos, Jackie Hollett-Caines, and Fawaz Edris 16. Hysteroscopic electrosurgical resection 110 Nikolaos P Papadopoulos and Adam Magos 17. Hysteroscopic laser ablation technique 122 David C Hunter 18. ThermaChoice balloon endometrial ablation 130 George A Vilos, Fawaz Edris, and Jackie Hollett-Caines 19. Cavaterm thermal balloon ablation 143 Britt Friberg 20. Thermablate EAS balloon endometrial ablation 148 George A Vilos, Jackie Hollett-Caines, and Fawaz Edris 21. Microwave endometrial ablation 157 Nicholas C Sharp 22. NovaSure endometrial ablation 166 Adolf Gallinat 23. Hydrothermablation 175 Mark H Glasser 24. Endometrial cryoablation 187 Andrea S Lukes 25. Vesta: distensible multielectrode balloon endometrial ablation 193 Kevin Jones 26. Randomized controlled trials in second-generation endometrial ablation 199 Paul McGurgan and Peter Joseph O’Donovan 27. Photodynamic therapy 210 Michael J Gannon 28. Hysteroscopic morcellation 215 Charles E Miller 29. Uterine artery embolization – the evidence 220 Anju Sinha and Janesh Gupta 30. Avoiding and managing laparoscopic complications in gynecologic surgery 226 Paul Tulikangas and Tommaso Falcone 31. Laparoscopic myomectomy 232 Charles E Miller 32. Hysteroscopic myomectomy: indications, technique, outcome, and complications 240 Aethele Khunda and Peter Joseph O’Donovan 33. Laparoscopic uterine artery occlusion 250 Moises Lichtinger Contents vii 34. Temporary occlusion of uterine artery for the treatment of fibroids 255 Olav Istre and Erik Qvigstad 35. Hysterectomy rate variations 260 Fulvio Zullo and Stefano Palomba 36. Total abdominal hysterectomy 267 Isaac T Manyonda and Essam Hadoura 37. Vaginal hysterectomy 280 Henri Clavé 38. Laparoscopic hysterectomy – historical perspective 291 Harry L Reich 39. Total laparoscopic hysterectomy 299 Charles E Miller 40. Laparoscopic supracervical hysterectomy 306 Thomas L Lyons and Wendy K Winer 41. Laparoscopic-assisted vaginal hysterectomy and abnormal uterine bleeding 312 Melissa Cameron and Peter J Maher 42. Laparoscopic hysterectomy for the large uterus 324 Pascale Jadoul and Jacques Donnez 43. Robotics: an evolving option in the management of abnormal uterine bleeding 331 Arnold P Advincula 44. Complications and clinical outcomes of hysterectomy 337 Craig Skidmore and Caroline E Overton 45. Comparison of hysterectomy techniques and cost–benefit analysis 346 Kirsten B Kluivers, Ben WJ Mol, Khalid S Khan, and Neil P Johnson 46. Analysis of sexual activity after hysterectomy 354 Sahana Gupta and Isaac Manyonda 47. Non-invasive surgery using magnetic resonance-guided focused ultrasound surgery technology 366 Richard Chudacoff 48. Future research in abnormal uterine bleeding 373 Marlies Y Bongers, Ben WJ Mol, Khalid S Khan, and Neil P Johnson Index 383 Contributors Arnold P Advincula MD Melissa Cameron BMBS (Hons) MPH FRANZCOG Department of Obstetrics and Gynecology Endosurgery Research Fellow University of Michigan Medical Center Mercy Hospital for Women Ann Arbor, MI Heidelberg USA Victoria Australia Maha Alkatib MRCOG Early Pregnancy, Gynecological Ultrasound Richard Chudacoff MD FACOG and MAS Unit Las Vegas International Center for
Load more

Recommended publications
  • Seco-Steroids C07C)
    CPC - C07J - 2021.08 C07J STEROIDS (seco-steroids C07C) Definition statement This place covers: Compounds containing a cyclopenta[a]hydrophenanthrene skeleton (see below) or a ring structure derived therefrom: • by contraction or expansion of one ring by one or two atoms; • by contraction or expansion of two rings each by one atom; • by contraction of one ring by one atom and expansion of one ring by one atom; • by substitution of one or two carbon atoms of the cyclopenta[a]hydrophenanthrene skeleton, which are not shared by rings, by hetero atoms, in combination with the above defined contraction or expansion or not, or; • by condensation with carbocyclic or heterocyclic rings in combination with one or more of the foregoing alterations or not. Preparation of steroids including purification, separation, stabilisation or use of additives unless provided for elsewhere, as specified below. Treatment and modification of steroids provided that • the treatment is not provided for elsewhere and • the resultant product is a compound under the subclass definition. Relationships with other classification places In class C07, in the absence of an indication to the contrary, a compound is classified in the last appropriate place, i.e. in the last appropriate subclass. For example cyclopenta [a] hydrophenantrenes are classified in subclass C07J as steroids and not in subclasses C07C or C07D as carbocyclic or heterocyclic compounds. Subclass C07J is a function-oriented entry for the compounds themselves and does not cover the application or use of the compounds under the subclass definition. For classifying such information other entries in the IPC exist, for example: Subclass A01N: Preservation of bodies of humans or animals or plants or parts thereof; biocides, e.g.
    [Show full text]
  • Dysmenorrhea Due to a Rare Müllerian Anomaly
    CASE REPORT Dysmenorrhea due to a rare müllerian anomaly M Agarwal, A Das, AS Singh Department of Obstetrics and Gynecology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences Shillong, India Abstract Müllerian duct anomalies may produce reproductive failure like abortion and preterm birth, or obstetric problems like malpresentation, retained placenta, etc., or they may be asymptomatic. Unicornuate uterus with a noncommunicating functional rudimentary horn is a type of müllerian anomaly that results in obstruction to menstrual blood flow, leading to endometriosis and dysmenorrhea. Though the majority of cases of dysmenorrhea in adolescents are primary in nature and require only reassurance and symptomatic management, it is important to be aware of rare causes such as müllerian anomalies so that these cases can be properly managed. Hence, we present this case report, with interesting illustrations, so as to increase awareness regarding these anomalies. Key words: Dysmenorrhea, müllerian anomaly, unicornuate uterus Date of Acceptance: 13-Feb-2011 Introduction department with complaints of severe pain in the lower abdomen during her menses for the last 6 months. Apart Unicornuate uterus with a rudimentary horn is a rare type from severe dysmenorrhea there was no other menstrual of müllerian duct malformation and is the result of defective abnormality. Her vitals and per abdominal examination fusion of the malformed duct with the contralateral duct.[1] findings were normal. Ultrasonography of the abdomen The incidence of unicornuate uterus, although not precisely suggested the possibility of unicornuate uterus with right- known, is estimated at 1/1000 women.[2] A noncommunicating sided hematosalpinx and hematometra; also, the right rudimentary horn with a functional endometrial cavity is rare kidney was not visualized.
    [Show full text]
  • N35.12 Postinfective Urethral Stricture, NEC, Female N35.811 Other
    N35.12 Postinfective urethral stricture, NEC, female N35.811 Other urethral stricture, male, meatal N35.812 Other urethral bulbous stricture, male N35.813 Other membranous urethral stricture, male N35.814 Other anterior urethral stricture, male, anterior N35.816 Other urethral stricture, male, overlapping sites N35.819 Other urethral stricture, male, unspecified site N35.82 Other urethral stricture, female N35.911 Unspecified urethral stricture, male, meatal N35.912 Unspecified bulbous urethral stricture, male N35.913 Unspecified membranous urethral stricture, male N35.914 Unspecified anterior urethral stricture, male N35.916 Unspecified urethral stricture, male, overlapping sites N35.919 Unspecified urethral stricture, male, unspecified site N35.92 Unspecified urethral stricture, female N36.0 Urethral fistula N36.1 Urethral diverticulum N36.2 Urethral caruncle N36.41 Hypermobility of urethra N36.42 Intrinsic sphincter deficiency (ISD) N36.43 Combined hypermobility of urethra and intrns sphincter defic N36.44 Muscular disorders of urethra N36.5 Urethral false passage N36.8 Other specified disorders of urethra N36.9 Urethral disorder, unspecified N37 Urethral disorders in diseases classified elsewhere N39.0 Urinary tract infection, site not specified N39.3 Stress incontinence (female) (male) N39.41 Urge incontinence N39.42 Incontinence without sensory awareness N39.43 Post-void dribbling N39.44 Nocturnal enuresis N39.45 Continuous leakage N39.46 Mixed incontinence N39.490 Overflow incontinence N39.491 Coital incontinence N39.492 Postural
    [Show full text]
  • Left Twisted Hydrosalpinx Presenting As Acute Abdomen
    The Journal of Obstetrics and Gynecology of India January/February 2011 pg 81 - 82 Case Report Left Twisted Hydrosalpinx Presenting as Acute Abdomen Pawar Uddhav1, Ghanekar Mahendra2 Department of Obstetrics and Gynaecology, Goa Medical College, Goa . A 30-year-old para 3 not sterilized was admitted on hemorrhage within i.e. in other words a left twisted 18.01.2006 with a history of acute pain in the abdomen hematosalpinx (Fig. 1 & 2 – the red arrow showing the of one day duration. She was in the 10th day post hematosalpinx and the gloved hand holding the uterus). menstrual cycle.. There was no history of dysmenorrhea. From the rest of her history all other The left ovary was normal and rest of the pelvic non gynecological causes of acute abdomen were ruled structures did not reveal any pathology. Left out. salpingectomy was done and as the patient desired ligation, right sided tubal ligation was also carried out. On examination her vitals were stable barring a mild The patient was discharged on 24.01.2006. The tachycardia; pulse rate=94/min. Per abdomen postoperative period was uneventful. The patient was examination there was tenderness in the left iliac fossa, given IV ofloxacin and IV-metronidazole for 24 hrs and no guarding or rigidity and bowel sounds were present. then switched over to oral ofloxacin for 10 days. She Bimanual pelvic examination revealed normal sized was asked to follow up with the histopathology reports uterus with tender cystic mass in left adnexa after 15 days. She followed up on 11.02.2006. The report approximately 4X4 cm and cervical motion tenderness was: gross - tube dilated and tortuous appearing bluish was positive.
    [Show full text]
  • Unusual Traumatic Uterine Injury: First Reported Cervicouterine Transection
    178 Case report Unusual traumatic uterine injury: first reported cervicouterine transection Ettedal A. Aljahdali Cervical agenesis is one of the Müllerian developmental management. Ann Pediatr Surg 14:178–181 © 2018 Annals anomalies that can occur and is usually associated with of Pediatric Surgery. vaginal atresia rarely isolated. Here we are reporting a case Annals of Pediatric Surgery 2018, 14:178–181 that has been referred as cervical agenesis and found to be a cervicouterine transection, so far not reported in literature. Keywords: cervical agenesis, cervicouterine transection, hematometra, primary amenorrhea, uterine injury We report a case of traumatic cervicouterine transection in 08/07/2018 on BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3l7ttZ9b/VuKxIwH3Dy/2pqEl0VxTbhh37J87j9nSKYU= by https://journals.lww.com/aps from Downloaded teenager patient who presented with amenorrhea and Department of Obstetrics and Gynecology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia hematometra. She was primarily investigated and found Downloaded to have intact full length cervical canal, normal uterus, Correspondence to Ettedal A. Aljahdali, MBBCh, SBOG, CBG OBGYN AFSA, Department of Obstetrics and Gynecology, King Abdulaziz University Hospital, and urinary system. Operative management confirmed PO Box 80215, Jeddah 21589, Saudi Arabia from our diagnosis of transection rather than agenesis with Tel: + 966 504 637 282; e-mail: [email protected] https://journals.lww.com/aps her history of trauma at
    [Show full text]
  • Isolated Twisted Hematosalphinx Misleading with Ovarian Cyst Torsion
    International Journal of Reproduction, Contraception, Obstetrics and Gynecology Khairnar V et al. Int J Reprod Contracept Obstet Gynecol. 2019 Mar;8(3):1219-1222 www.ijrcog.org pISSN 2320-1770 | eISSN 2320-1789 DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20190911 Case Report Isolated twisted hematosalphinx misleading with ovarian cyst torsion Vaibhav Khairnar*, Shalini Mahana Valecha, Pandeeswari Department of Obstetrics and Gynecology, ESI-PGIMSR, Mumbai, Maharashtra, India Received: 05 December 2018 Accepted: 05 February 2019 *Correspondence: Dr. Vaibhav Khairnar, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Normal or chronically inflamed fallopian tube can undergo torsion and present as acute abdomen, simulating clinically as ectopic gestation. Torsion of the fallopian tube is less frequent but significant cause of lower abdominal pain in reproductive age women that is difficult to recognize preoperatively. Authors present a rare case of hematosalpinx with torsion at its pedicle with hemoperitonium who presented as 28 years old female with acute abdomen that was successfully treated. In cases presenting with hemoperitoneum diagnosis of ruptured ectopic pregnancy should be made unless proved otherwise during reproductive age. Rarely ruptured ovarian cyst may also be a cause. Unfortunately, hematosalpinx sometimes can undergo torsion due to circulatory imbalance and can present as hemoperitoneum and circulatory collapse due to rupture. There have been no specific symptoms, clinical findings, imaging or laboratory characteristics identified for this condition.
    [Show full text]
  • United States Patent (19) 11 Patent Number: 4,585,591 Nitta Et Al
    United States Patent (19) 11 Patent Number: 4,585,591 Nitta et al. (45) Date of Patent: Apr. 29, 1986 (54) 17B-ETHYNYLSTEROIDs AND PROCESS 56) References Cited FOR PREPARNG SAME U.S. PATENT DOCUMENTS 75) Inventors: Issei Nitta, Machida; Shinichiro 3,023,206 2/1962 Burnet al. ..................... 260/239.55 Fujimori, Yokohama; Toshio Haruyama, Sagamihara; Shinya FOREIGN PATENT DOCUMENTS Inoue, Yamato, all of Japan 845441 8/1960 United Kingdom ............. 260/397.4 73 Assignee: Mitsubishi Chemical Industries, Ltd., OTHER PUBLICATIONS Tokyo, Japan L. A. van Dijck et al., "Synthesis and Reactions of 3-Methoxy-17-Hydroxy-17-Ethynyl-1,3,5(10)-Estra 21 Appl. No.: 325,026 triene', Recueil Journal of the Royal Netherlands Chemical Society, 96,7-8, Jul.-Aug., pp. 200-205 22 Filed: Nov. 25, 1981 (1977). Primary Examiner-Elbert L. Roberts 30 Foreign Application Priority Data Attorney, Agent, or Firm-Oblon, Fisher, Spivak, Dec. 10, 1980 JP Japan ................................ 55-174065 McClelland & Maier Dec. 10, 1980 JP Japan ... ... 55-174.066 Feb. 23, 1981 JP Japan .................................. 56-25307 (57) ABSTRACT Jul. 28, 1981 (JP) Japan ................................ 56-18343 This is disclosed novel intermediates, i.e. 1743-ethynyl steroids, which are useful for the preparation of corti 51) Int. Cl. .................................................. CO7J 1/00 coids such as hydrocortisone and prednisolone, and a 52 U.S. C. ............................ 260/3974; 260/397.45; process for preparing the same. 260/239.55 C, 260/397.5; 260/397.47 58) Field of Search ......................... 260/397.4, 397.45 4 Claims, No Drawings 4,585,591 1 2 17(3-ETHYNYLSTEROIDS AND PROCESS FOR -continued PREPARING SAME CECH BACKGROUND OF THE INVENTION This invention relates to a novel intermediate for use in the preparation of corticoids (adrenocortical hor mones) such as hydrocortisone, prednisolone and the MeO like.
    [Show full text]
  • A Choice for Treatment of Heavy Menstrual Bleeding
    D 1205 OULU 2013 D 1205 UNIVERSITY OF OULU P.O.B. 7500 FI-90014 UNIVERSITY OF OULU FINLAND ACTA UNIVERSITATIS OULUENSIS ACTA UNIVERSITATIS OULUENSIS ACTA SERIES EDITORS DMEDICA Sari Ahonkallio ASCIENTIAE RERUM NATURALIUM Sari Ahonkallio Senior Assistant Jorma Arhippainen ENDOMETRIAL THERMAL BHUMANIORA ABLATION University Lecturer Santeri Palviainen CTECHNICA A CHOICE FOR TREATMENT OF HEAVY Docent Hannu Heusala MENSTRUAL BLEEDING DMEDICA Professor Olli Vuolteenaho ESCIENTIAE RERUM SOCIALIUM University Lecturer Hannu Heikkinen FSCRIPTA ACADEMICA Director Sinikka Eskelinen GOECONOMICA Professor Jari Juga EDITOR IN CHIEF Professor Olli Vuolteenaho PUBLICATIONS EDITOR Publications Editor Kirsti Nurkkala UNIVERSITY OF OULU GRADUATE SCHOOL; UNIVERSITY OF OULU, FACULTY OF MEDICINE, ISBN 978-952-62-0142-9 (Paperback) INSTITUTE OF CLINICAL MEDICINE, ISBN 978-952-62-0143-6 (PDF) DEPARTMENT OF OBSTETRICS AND GYNECOLOGY; ISSN 0355-3221 (Print) OULU UNIVERSITY HOSPITAL ISSN 1796-2234 (Online) ACTA UNIVERSITATIS OULUENSIS D Medica 1205 SARI AHONKALLIO ENDOMETRIAL THERMAL ABLATION A choice for treatment of heavy menstrual bleeding Academic dissertation to be presented with the assent of the Doctoral Training Committee of Health and Biosciences of the University of Oulu for public defence in Auditorium 4 of Oulu University Hospital, on 7 June 2013, at 12 noon UNIVERSITY OF OULU, OULU 2013 Copyright © 2013 Acta Univ. Oul. D 1205, 2013 Supervised by Docent Markku Santala Professor Hannu Martikainen Reviewed by Doctor Jyrki Jalkanen Docent Maritta Hippeläinen ISBN 978-952-62-0142-9 (Paperback) ISBN 978-952-62-0143-6 (PDF) ISSN 0355-3221 (Printed) ISSN 1796-2234 (Online) Cover Design Raimo Ahonen JUVENES PRINT TAMPERE 2013 Ahonkallio, Sari, Endometrial thermal ablation. A choice for treatment of heavy menstrual bleeding University of Oulu Graduate School; University of Oulu, Faculty of Medicine, Institute of Clinical Medicine, Department of Obstetrics and Gynecology, P.O.
    [Show full text]
  • GC/C/IRMS) Als Potentielle Untersuchungsmethode Zum Nachweis Einer Illegalen Anwendung Von 19-17 Βββ-Nortestosteron in Der Ebermast
    Einsatz der Stabilisotopen-Massenspektrometrie (GC/C/IRMS) als potentielle Untersuchungsmethode zum Nachweis einer illegalen Anwendung von 19-17 βββ-Nortestosteron in der Ebermast Dissertation zur Erlangung des akademischen Doktorgrades der Naturwissenschaften an der Bergischen Universität im Fachbereich Mathematik und Naturwissenschaften Die Arbeit wurde in der Zeit vom 15. Mai 2003 bis 31.Dezember 2006 am Chemischen und Veterinäruntersuchungsamt in Freiburg angefertigt vorgelegt von Annette Mertineit-Heinz Wuppertal 2007 Diese Dissertation kann wie folgt zitiert werden: urn:nbn:de:hbz:468-20070870 [http://nbn-resolving.de/urn/resolver.pl?urn=urn%3Anbn%3Ade%3Ahbz%3A468-20070870] dem Allmächtigen Gott Das Geheimnis Gottes ist Jesus Christus, in dem alle Schätze der Weisheit und Erkenntnis verborgen sind. Die Bibel , Kolosser 2, 3 Dank Mein besonderer Dank gilt Herrn Prof. Dr. Michael Petz, der es mir ermöglichte, an der Universität Wuppertal diese Dissertation anzufertigen. Für seine Hilfsbereitschaft und Ermutigungen bin ich ihm sehr dankbar. Bedanken möchte ich mich beim Amtsleiter des CVUA Herrn Dr. Roland Renner sowie Laborleiter Herrn Dr. Martin Metschies, dass ich die Untersuchungen für diese Arbeit am CVUA durchführen durfte. Bei Laborleiterin Frau Dr. Eva Annweiler möchte ich mich für ihre vielseitige Unterstützung in analytischen Fragen und ihre Hilfe bei der Durchsicht der Arbeit bedanken. Den Labormitarbeitern Herrn Thomas Huber danke ich für die Unterstützung bei den EA/IRMS-Messungen, Frau Sylvia Scanlan-Sierra bei den GC/MS-Messung und Herrn Manfred Grosse bei den GC/FID-Messungen. Herr Grosse hat sich immer Zeit genommen, mich zu unterstützen, ohne dabei seine tägliche Arbeit zu vernach- lässigen. Für die Unterstützung der Aufarbeitung der Eberurine gilt mein Dank Laborleiter Herr Lippold und den Mitarbeitern Frau Annabarbara Fies, Herrn Markus Roth und Frau Maria Schmidt.
    [Show full text]
  • Radiological Findings of Uterine Arteriovenous Malformation
    Farias MS et Caseal. / Uterine Report arteriovenous malformation: a case report Radiological findings of uterine arteriovenous malformation: a case report of an unusual and life-threatening cause of abnormal vaginal bleeding* Aspectos radiológicos da malformação arteriovenosa uterina: relato de caso de uma causa incomum e perigosa de sangramento vaginal anormal Marcela Sales Farias1, Clara Campagnaro Santi1, Aline Aparecida A. de A. Lima2, Sabrina Mendes Teixeira3, Tatiana Co Gomes De Biase4 Farias MS, Santi CC, Lima AAAA, Teixeira SM, De Biase TCG. Radiological findings of uterine arteriovenous malformation: a case report of an unusual and life-threatening cause of abnormal vaginal bleeding. Radiol Bras. 2014 Mar/Abr;47(2):122–124. Abstract Uterine arteriovenous malformations may cause life-threatening abnormal genital bleeding in women at childbearing age. Transvaginal Doppler ultrasonography is a widely available, noninvasive and excellent diagnostic method. The authors report the case of a patient with history of gestational trophoblastic disease and multiple curettage procedures who developed uterine arteriovenous malformations, with remission of the lesions after treatment with methotrexate. Keywords: Arteriovenous malformations; Doppler; Abnormal genital bleeding. Resumo Malformações arteriovenosas uterinas podem causar sangramento genital anormal, representando risco de morte nas mulheres em idade reprodutiva. O ultrassom transvaginal com Doppler é um método não invasivo amplamente disponível e excelente ferramenta diagnóstica.
    [Show full text]
  • United States Patent Office Patented Jan
    3,231,567 United States Patent Office Patented Jan. 25, 1966 2 droxy ethylene, hydroxy propylene, hydroxybutylene and 3,231,567 PROCESS FOR THE PREPARATION OF 3-HY the like; a saturated or unsaturated cycloaliphatic moiety, DROXY. AND 3-ALKOXY-ESTRATRIENES such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, AND INTERMEDIATES THEREFOR cyclopentenyl, cyclohexenyl, cyclopentylpropyl, cyclo Alberto Ercoli and Rinaldo Gardi, Milan, and Cesare 5 heptyl, cyclooctyl radical; or an araliphatic moiety, such Pedrai, Bergamo, Italy, assignors to Francesco Wismara as benzyl, phenetyl, cynnamyl radical. Preferred hydro S.p.A., Casadenovo, Italy carbon radicals are aliphatic moieties containing from 1 No Drawing. Fied Dec. 16, 1963, Ser. No. 330,584 to 8 carbon atoms, inclusive, cycloaliphatic moieties con Claims priority, application Italy, Dec. 19, 1962, taining from 5 to 6 carbon atoms in the ring and the Patent 24,856/62 benzyl radical. 20 Claims. (C. 260-239.55) 10 Methods for the aromatization of the ring A of 19-nor This invention relates to an improved process for con steroids are already known in the literature and the prior verting steroids of the 19-nor-androstane and 19-nor-preg art teaches the conversion of a 3-keto-19-norsteroid of name series into derivatives of the estrogenic series. The the androstane series into a derivative of the estrogenic invention also relates to certain new 19-norsteroid deriva 5 series. This conversion may be accomplished by first tives useful as intermediates in said conversion. preparing a 5,10-epoxy-estren-3-one or a 3-ketal thereof More particularly, this invention is concerned with a by epoxiding a 5 (10)-estrene-3-one or A-3-keto-19-nor amethod for the aromatization of the ring A to produce steroid 3-ketal, respectively, with a peracid.
    [Show full text]
  • Niche Role of MRI in the Evaluation of Female Infertility
    Published online: 2021-07-19 OBS AND GYNECOLOGY Niche role of MRI in the evaluation of female infertility Shabnam Bhandari Grover, Neha Antil, Amit Katyan, Heena Rajani, Hemal Grover1, Pratima Mittal2, Sudha Prasad3 Departments of Radiology and Imaging and 2Obstetrics and Gynecology, Vardhman Mahavir Medical College and Safdarjung Hospital, 3Department of Obstetrics and Gynecology, Maulana Azad Medical College, New Delhi, India, 1Department of Radiology, Icahn School of Medicine at Mount Sinai West, New York, USA Correspondence: Dr. Shabnam Bhandari Grover, E-81, Kalkaji, New Delhi - 110 019, India. E-mail: [email protected] Abstract Infertility is a major social and clinical problem affecting 13–15% of couples worldwide. The pelvic causes of female infertility are categorized as ovarian disorders, tubal, peritubal disorders, and uterine disorders. Appropriate selection of an imaging modality is essential to accurately diagnose the aetiology of infertlity, since the imaging diagnosis directs the appropriate treatment to be instituted. Imaging evaluation begins with hystero‑ salpingography (HSG), to evaluate fallopian tube patency. Uterine filling defects and contour abnormalities may be discovered at HSG but usually require further characterization with pelvic ultrasound (US), sono‑hysterography (syn: hystero‑sonography/saline infusion sonography) or pelvic magnetic resonance imaging (MRI), when US remains inconclusive. The major limitation of hysterographic US, is its inability to visualize extraluminal pathologies, which are better evaluated by pelvic US and MRI. Although pelvic US is a valuable modality in diagnosing entities comprising the garden variety, however, extensive pelvic inflammatory disease, complex tubo‑ovarian pathologies, deep‑seated endometriosis deposits with its related complications, Mulllerian duct anomalies, uterine synechiae and adenomyosis, often remain unresolved by both transabdominal and transvaginal US.
    [Show full text]